🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase I double-blind, randomized, placebo-controlled study in 50 ...
Status
Completed
Location
Saint Louis University - Center for Vaccine Development
Start Date
2018-08-15
Trial ID
NCT03553940
Influenza (flu) viruses change continuously, therefore also the parts of vi...
Status
Completed
Location
Site Reference ID/Investigator# 59243
Start Date
2009-06
Trial ID
NCT00881842
Treatments Being Tested
The purpose of this study is explore the antibody and cell mediated immune ...
Status
Completed
Location
Azienda Ospedaliera Universtaria Senese
Start Date
2009-12
Trial ID
NCT01079273
Treatments Being Tested
The aim of the study to assess the safety, reactogenicity, immunogenicity, ...
Status
Completed
Location
Federal State Budgetary Educational Institution of Higher Education "First St. Petersburg State Medical University named after academician I.P. Pavlova "of the Ministry of Health of the Russian Federation.
Start Date
2016-11
Trial ID
NCT03849560
This study will evaluate the safety and immunogenicity in healthy children ...
Status
Completed
Location
Centro de Atención e Investigación Medica - CAIMED
Start Date
2010-09
Trial ID
NCT01209780
Treatments Being Tested
This is an observational safety study of a prophylactic use of Flu Egg Deri...
Status
Completed
Location
Hospital Garrahan
Start Date
2009-12
Trial ID
NCT01040741
Treatments Being Tested
The present study will evaluate clinical efficacy, safety, tolerability and...
Status
Completed
Location
Site 14
Start Date
2007-10
Trial ID
NCT00630331
Treatments Being Tested
This is a study to evaluate the immune response and safety of GSK Biologica...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-11-11
Trial ID
NCT00197236
A Phase III, Randomized, Observer-Blind, Controlled, Multicenter Clinical S...
Status
Completed
Location
MHAT St. Ekaterina
Start Date
2016-09-30
Trial ID
NCT02587221
The purpose of this study is to describe the immunogenicity and safety of t...
Status
Completed
Location
Multiple Locations
Start Date
2013-09
Trial ID
NCT02344134
Treatments Being Tested